Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Terminated 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1Lymphoid 1

Conditions

Leukemia, Myelogenous, Chronic, BCR-ABL Positive 142Leukemia 69Leukemia, Myeloid, Chronic-Phase 50Precursor Cell Lymphoblastic Leukemia-Lymphoma 43Blast Crisis 22Philadelphia Chromosome 14Leukemia, Myeloid, Acute 12Leukemia, Myeloid, Accelerated Phase 12Leukemia, Myeloid 9Leukemia, Myelomonocytic, Chronic 7Primary Myelofibrosis 6Hematologic Neoplasms 6Myeloproliferative Disorders 5Hematologic Diseases 5Bone Marrow Diseases 5Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 4Multiple Myeloma 4Leukemia, Lymphocytic, Chronic, B-Cell 4Hypereosinophilic Syndrome 4Gastrointestinal Stromal Tumors 4Bronchiolitis Obliterans Syndrome 4Recurrence 3Polycythemia Vera 3Neoplasms 3Neoplasm, Residual 3Myelodysplastic Syndromes 3Lymphoma 3Leukemia, Myelomonocytic, Acute 3Leukemia, Monocytic, Acute 3Leukemia, Megakaryoblastic, Acute 3

Interventions

blinatumomab 4fludarabine 3Rituximab 3Cyclophosphamide 3ponatinib 2ibrutinib 2fludarabine phosphate 2Whole-Body Irradiation 2Tacrolimus 2Peripheral Blood Stem Cell Transplantation 2Patient Reported Outcome Measures 2Mycophenolic Acid 2Mesna 2Melphalan 2Busulfan 2Bone Marrow Transplantation 2venetoclax 1tetulomab tetraxetan lu-177 1pomalidomide 1obinutuzumab 1durvalumab 1dacetuzumab 1amonafide 1acalabrutinib 1Tinzaparin 1Lutetium-177 1Lutetium 1Lenalidomide 1Imatinib Mesylate 1Everolimus 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Lymphatic Diseases × Imatinib Mesylate × Other hematologic neoplasm × Clear all
NCT01650805 2014-11-17

Ponatinib in Newly Diagnosed Chronic Myeloid Leukemia (CML) (EPIC)

Ariad Pharmaceuticals

Phase 3 Terminated
307 enrolled 11 charts
LymphoidMyeloidOther hematologic neoplasm

Bone Marrow Diseases, Hematologic Diseases, Immune System Diseases, Immunoproliferative Disorders, Leukemia, Leukemia, Myeloid, Lymphatic Diseases, Lymphoproliferative Disorders, Myeloproliferative Disorders, Neoplasms, Neoplasms by Histologic Type, Leukemia, Myelogenous, Chronic, BCR-ABL Positive

Data powered by HemOnc (CC BY 4.0) Colophon âš¡